论文部分内容阅读
今年7月,全球最大制药企业辉瑞公司宣称,将剥离包括惠氏婴幼儿奶粉在内的营养品业务和动物保健业务,售价高达100亿美元。此消息震动全球制药界和乳品业。世界各大乳业公司竞相参与收购。更具备戏剧性的是,10月24日,英国《金融时报》报道称,由中粮控股的中国最大乳业公司蒙牛乳业(集团)股份有限公司正为此和中介瑞银接洽,考虑参与竞购。而倘若蒙牛竞购成功,将成为三聚氰胺事件后一宗国内乳企收购海外乳业资产的案例,标志着中国乳品企业已重返全球收购交易市场的大门,国产奶粉或将重振河山。
In July of this year, Pfizer, the world’s largest pharmaceutical company, announced that it would strip its nutrition business and animal health business, including its infant formula, for as much as $ 10 billion. The news shocked the global pharmaceutical industry and the dairy industry. The world’s major dairy companies compete to participate in the acquisition. Even more dramatic is that on October 24, the Financial Times reported that Mengniu Dairy (China) Co., Ltd., China’s largest dairy company controlled by Cofco, is approaching the agency UBS for bidding. In the meantime, Mengniu’s bid will be a case of a domestic dairy company acquiring overseas dairy assets after the melamine incident, which marks the door for Chinese dairy companies to return to the global takeover market. Domestic milk powder may revive.